ArticleClinical and translational medicine2025

Advanced mutant receptor activator of nuclear factor kappa-Β ligand development with low affinity for osteoprotegerin.

Yuria Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.